ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Joincare Pharmaceutical Group Industry Co., Ltd. clinical trials

Part of Shenzhen Baiyeyuan Investment Co., Ltd., which holds 48.96% as of 2025-12-31. Source

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 37 studies whose lead sponsor is Joincare Pharmaceutical Group Industry Co., Ltd. or the company grouped under it. 7 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 15, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare Joincare Pharmaceutical Group Industry with Sino Biopharmaceutical and Jiangsu HengRui Medicine →

Pipeline: 11 programs

Each counted once: 11 with a study Joincare Pharmaceutical Group Industry Co., Ltd. leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 4 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Joincare Pharmaceutical Group Industry Co., Ltd.’s own registered studies; Joincare Pharmaceutical Group Industry Co., Ltd.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Joincare Pharmaceutical Group Industry Co., Ltd.’s studies test, most open studies first — 3 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

1 of Joincare Pharmaceutical Group Industry Co., Ltd.’s studies under way reach primary completion within a year, all of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. 1S
  12. O
  13. N

The study

Add it to your calendar (.ics) → With an account.

All 37 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now719%Recruiting 6 · Not yet recruiting 1
  • Completed1951%
  • Status unknown or other1130%

Phase

  • Phase 312
  • Phase 211
  • Phase 17
  • Phase 43
  • Early Phase 12

Where

  • China25
  • United States2
  • Pakistan1
  • Philippines1
  • Russian Federation1
  • Malaysia1

Over the years

  1. 08
  2. 09
  3. 10
  4. 11
  5. 12
  6. 13
  7. 14
  8. 15
  9. 16
  10. 17
  11. 18
  12. 19
  13. 20
  14. 721
  15. 22
  16. 23
  17. 24
  18. 25
  19. 126

By the year each study started; 2 started before 2008. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Joincare Pharmaceutical Group Industry Co., Ltd.

  • Livzon Pharmaceutical Group Inc.
    Acquired — became part of Joincare Pharmaceutical Group Industry Co., Ltd., 2002 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    28 studies →
  • Joincare Pharmaceutical Group Industry Co., Ltd
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    9 studies

Studies

Recruiting first, then most recently updated. Showing 37 of 37.